Is Reimbursement A Game Changer For Deal Structures? Industry Execs Weigh In
This article was originally published in The Pink Sheet Daily
Executive Summary
Bristol-Myers Squibb's Jeremy Levin admits "a degree of ignorance" about the impact of reimbursement in deal structures.